ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Given Consensus Rating of "Moderate Buy" by Brokerages
Shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Get Free Report) have received a consensus rating of "Moderate Buy" from the nine analysts that are covering the firm, MarketBeat.com reports. Three...